SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Electra Battery Materials Corp. engages in the refining, acquisition, and exploration of resource properties. Its project portfolio includes Iron Creek and Battery Materials Park. The company was founded on July 13, 2011 and is headquartered Toronto, Canada.

Electra Battery Materials Corp

Electra Battery Materials Corp is trending due to a recently secured $30 million financing deal and positive analyst ratings, potentially enabling the company to complete its cobalt refinery. The community is actively discussing the stock's momentum, potential for a short squeeze given the high borrowing fees, and its strategic positioning in the North American EV supply chain. Some see the stock as undervalued with significant upside potential, while others are wary of dilution and execution risks.

Microvast Holdings, Inc. is an advanced battery technology company. It engages in the business of designing, developing, and manufacturing battery components and systems primarily for electric commercial vehicles and utility-scale energy storage systems. The company was founded by Yang Wu on October 12, 2006 and is headquartered in Stafford, TX.

Microvast Holdings Inc

Microvast ($MVST) is trending as the community discusses its potential for significant growth, highlighting its small float, low short interest, and progress in EU revenues. Some believe the stock is undervalued compared to competitors like $QS and are anticipating a substantial move towards higher valuations, possibly reaching three-digit figures long term. Bullish sentiment is fueled by positive technical indicators and upcoming Q3 earnings, with some eyeing a potential short squeeze.

RAGE GUY (RAGE) is a cryptocurrency inspired by the Rage Guy meme, one of the earliest and most recognizable characters from internet rage comics. The project captures the cultural legacy of early meme history and brings it onto the blockchain in tokenized form. It is designed as a community-driven digital asset that celebrates internet culture, nostalgia, and the role memes play in shaping online communities.

Rage Guy

RAGE CRYPTO is trending as the community rallies behind the OG meme coin, emphasizing its resilience amid market volatility. Discussions highlight the strength of the community, with many expressing bullish sentiment and encouraging others to embrace the 'rage' and 'send it' to new heights. The return of rage comics and memetic energy are central to the current conversation.

$WAGMI is a community-driven meme token built on the Solana blockchain, designed to bring positivity, unity, and humor into the crypto space. The project encourages community engagement through memes, social interaction, and token-based activities. It leverages Solana’s fast and low-cost infrastructure to allow for smooth on-chain interactions, such as token transfers, community games, and NFT integration. The goal is to foster a fun, inclusive ecosystem where holders feel they are part of a larger movement – "We Are Gonna Make It."

WAGMI

WAGMI is gaining traction, with community members actively discussing its potential and strong mindshare, while also commenting on the recent market volatility. Some are highlighting its resilience, the strength of its community, and comparing it to other meme coins on the Solana blockchain. The project's website is being shared as a resource for those looking to learn more.

United States Antimony Corp. engages in the extraction, processing and sale of antimony, zeolite, silver, and gold products. It operates through the following segments: United States Antimony Operations, Mexican Antimony Operations, Precious Metals Recovery, and United States Zeolite Operations. The company was founded by John C. Lawrence in June 1968 and is headquartered in Thompson Falls, MT.

United States Antimony Corp.

United States Antimony Corp

United States Antimony Corp is trending due to increased interest in domestic antimony production amid rising trade tensions with China and a looming export ban. The community is discussing the company's potential for growth, government contracts, and comparison to other rare earth stocks like MP Materials. Some anticipate significant price increases and a potential government stake in the company.

Solidion Technology, Inc. engages in researching, developing and manufacturing battery components and materials, batteries and related energy storage products for the automotive electric vehicle and other markets. The company was founded on June 30, 2023 and is headquartered in Dallas, TX.

Solidion Technology Inc

STI is trending due to excitement surrounding its new AI data-center UPS system, highlighting potential commercialization and significant order prospects. The community is focused on the low float and potential for a major squeeze, drawing comparisons to other high-momentum stocks in the clean energy and battery sectors. Discussions also include speculation about potential offerings and the company's long-term prospects in the rapidly growing AI infrastructure market.

Rigetti Computing, Inc. provides full-stack quantum computing services. It serves global enterprise, government, and research clients through its Rigetti Quantum Cloud Services platform. The company was founded by Chad Rigetti in 2013 and is headquartered in Berkeley, CA.

Rigetti Computing Inc

RGTI is trending as retail traders discuss the stock's parabolic rise and potential gamma squeeze, with many highlighting the disconnect between its market cap and revenue. Community members are debating whether the surge is sustainable or if a significant correction is imminent, while some speculate about potential catalysts like acquisitions or further investment in the quantum computing sector. Overall, the conversation reflects a mix of excitement and caution regarding the stock's valuation.

Develops, designs, manufactures and installs micro modular reactors

Terra Innovatum Global N.V.

Terra Innovatum Global N.V. Ordinary shares

Terra Innovatum ($NKLR) is trending as the merger is complete and the ticker has changed, with the community drawing comparisons to other nuclear plays like $OKLO and anticipating a significant run. Discussions revolve around the perceived undervaluation relative to peers in the sector and potential catalysts like ringing the opening bell at NASDAQ. Investors are also monitoring share conversions across brokerages and anticipating option chain updates.

Navitas Semiconductor Corp. engages in the development of ultra-efficient gallium nitride (GaN) semiconductors. Its GaN power ICs integrate GaN power with drive, control and protection to enable charging, power density, and energy savings for mobile, consumer, enterprise, eMobility and new energy markets. The company was founded by Daniel Kinzer, Nick Fichtenbaum, Gene Sheridan, and Jason Zhang on August 12, 2020 and is headquartered in Torrance, CA.

Navitas Semiconductor Corp

NVTS is trending as traders discuss its potential link to NVDA and the broader AI sector, with some speculating about a possible acquisition or partnership. Community members are closely watching volume and order flow, anticipating a potential squeeze and further upside. Some are also pointing to the company's shift in GaN orders and its potential impact on future revenue.

JPMorgan Chase & Co. is a financial holding company, which engages in the provision of financial and investment banking services. It focuses on investment banking, financial services for consumers and small businesses, commercial banking, financial transaction processing, and asset management. It operates through the following segments: Consumer and Community Banking (CCB), Commercial and Investment Bank (CIB), Asset and Wealth Management (AWM), and Corporate. The CCB segment originates and services mortgage loans. The CIB segment makes markets and services clients across fixed income, foreign exchange, equities, and commodities. The AWM segment provides initial capital investments in products such as mutual funds and capital invested alongside third-party investors. The Corporate segment manages its liquidity, funding, capital, structural interest rate, and foreign exchange risks. The company was founded in 1799 and is headquartered in New York, NY.

JPMorgan Chase & Co.

JPMorgan Chase & Co

JPMorgan is trending due to discussions surrounding potential earnings beats and a recently announced $1.5 trillion investment plan in U.S. security industries, including frontier technologies like quantum computing. The community is weighing the potential for higher revenue and EPS against concerns about NII guidance and the possibility of an earnings fade. Some traders are also speculating about JPM's potential role in supporting quantum computing firms and national security initiatives, while others are wary of potential market corrections.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fortress Biotech Inc. - FBIO

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fortress Biotech Inc. - FBIO INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fortress...

Fortress Biotech, Inc. (FBIO) shares slumped 30% in the pre-market session on Wednesday after the company announced that the U.S. Food and Drug Administration refused to approve CUTX-101 for the treatment of Menkes disease in pediatric patients.The FDA, in its letter, flagged concerns about the facility where CUTX-101 is manufactured. The letter did not cite any other approvability concerns or any deficiencies pertaining to CUTX-101’s efficacy and safety data, the company <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.globenewswire.com/news-release/2025/10/01/3159486/28889/en/Fortress-Biotech-and-Cyprium-Therapeutics-Announce-an-Update-on-the-NDA-for-CUTX-101.html">said</a>.U.S.-based biopharmaceutical company Sentyl Therapeutics is responsible for the development and commercialization of CUTX-101. It took over the responsibility from Fortress’s majority-owner unit, Cyprium Therapeutics, in December 2023.Fortress said on Wednesday that Cyprium expects Sentynl to work expeditiously to address the FDA’s concerns and pursue resubmission promptly.On Stocktwits, retail sentiment around <a href="https://stocktwits.com/symbol/FBIO">FBIO stock</a> rose from ‘bullish’ to ‘extremely bullish’ over the past 24 hours, while message volume improved from ‘high’ to ‘extremely high’ levels.The facility in question recently responded to the FDA’s September 2025 re-inspection, and Sentynl expects to request a meeting with the agency to discuss resubmission of the drug application, according to Fortress.Under the deal between Cyprium and Sentynl, Cyprium will be eligible to receive royalties on net sales of CUTX-101, if approved in the treatment of Menkes disease, and up to $129 million in aggregate development and sales milestones from Sentynl. Menkes disease is a rare, severe genetic disorder primarily affecting males, which impairs the body's ability to absorb and distribute copper, resulting in copper deficiency in the brain and other organs.FBIO stock is up 82% this year and approximately 158% over the past 12 months.&nbsp;Read also:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/carvana-stock-rallies-pre-market-after-jefferies-upgrade-price-target-hike/chCY5oIR3aK">Carvana Stock Rallies Pre-Market After Jefferies’s Upgrade, Price Target Hike</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Stock market down on a black background. | Image source: Yuichiro Chino via Getty Images

Why Is Fortress Biotech Stock Falling Today?

The FDA, in a letter, flagged concerns about the facility where CUTX-101 is manufactured.

Equity

The FDA, in a letter, flagged concerns about the facility where CUTX-101 is manufactured.



Fortress Biotech (FBIO) Reports Q2 Loss, Beats Revenue Estimates

Fortress Biotech (FBIO) delivered earnings and revenue surprises of -48.39% and +13.66%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Repare Therapeutics Inc. (RPTX) Reports Q2 Loss, Misses Revenue Estimates

Repare Therapeutics (RPTX) delivered earnings and revenue surprises of +30.36% and -95.00%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Coherus Oncology (CHRS) Reports Q2 Loss, Beats Revenue Estimates

Coherus Oncology (CHRS) delivered earnings and revenue surprises of -9.68% and +1.32%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Why Fast-paced Mover Fortress Biotech (FBIO) Is a Great Choice for Value Investors

If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, Fortress Biotech (FBIO) could be a great choice. It is one of the several stocks that passed through our 'Fast-Paced Momentum at a Bargain' screen.

Ultragenyx (RARE) Surges 5.1%: Is This an Indication of Further Gains?

Ultragenyx (RARE) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

Despite Fast-paced Momentum, Fortress Biotech (FBIO) Is Still a Bargain Stock

Fortress Biotech (FBIO) Is Attractively Priced Despite Fast-paced Momentum

New Strong Sell Stocks for May 16th 

Fortress Biotech, Inc. engages in the manufacture and commercialization of novel pharmaceutical products and product candidates. It operates through the Dermatology Product Sales and Pharmaceutical and Biotechnology Product Development segments. Its products include Ximino, Targadox, Exelderm, Ceracade, and Luxamend. The company was founded in 2006 and is headquartered in Bay Harbor Islands, FL.

Fortress Biotech Inc

Cut 25 bps

Cut 50+ bps

No change

What will the Fed decide at its October meeting? Polymarket gives a 92% chance of a 25 bps cut. 
 
*Powered by Polymarket

Current Price	$2.79
Prev Close	$2.71
Open	$2.71
Dividend Yield	0.00%
50-Day Moving Average	$2.85
Beta	0.88
Avg. Volume	1.61M
PE Ratio	-2.37

52-Week High	$4.20
52-Week Low	$1.33
Market Capitalization	$80.64M
EPS (Annual)	-$2.69
Price to Book	1.84
Revenue Per Employee	$571,039.60
Enterprise Value/EBITDA	N/A

FBIO
Fortress Biotech Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest FBIO News

FBIOFortress Biotech Inc